Company Filing History:
Years Active: 2003-2016
Title: Innovator Wilhelmus Martinus Maria Schaaper: Pioneering Advances in Trisaccharide Derivatives and Antifungal Peptides
Introduction
Wilhelmus Martinus Maria Schaaper is a notable inventor based in Almere, Netherlands. With a promising portfolio of two patents, Schaaper has made significant contributions to the fields of biotechnology and agriculture. His innovative work centers around the creation and application of novel compounds that can be used in various industries, including pharmaceuticals and agriculture.
Latest Patents
Schaaper’s latest patents focus on two groundbreaking inventions. The first is related to "Trisaccharide Derivatives and Their Use as Adjuvants". This invention describes the use of trisaccharide derivatives with a fully substituted trisaccharide core, enhanced by fatty acid ester groups and optionally incorporating one or more anionic groups. These derivatives serve as effective adjuvants, with applications extending to the production of vaccines or kits that utilize these compositions.
The second patent, "Antifungal Peptides and Composition Thereof", details antifungal peptides comprising at least six amino acid residues identical to a sequence found in the Rs-AFP2 antifungal protein. These peptides are valuable for combating fungal diseases across agricultural, pharmaceutical, and preservative contexts.
Career Highlights
Throughout his career, Schaaper has held positions in prominent companies such as Syngenta Corporation and Immunovo B.V. His work within these organizations has allowed him to develop and refine his innovative ideas, leading to the successful filing of his patents.
Collaborations
Schaaper has worked alongside esteemed colleagues, including Aart Van Amerongen and Franky Fant. These collaborations have facilitated the exchange of ideas and expertise, fostering a productive environment conducive to innovation.
Conclusion
Wilhelmus Martinus Maria Schaaper has established himself as a key inventor in his field, with patents that hold significant potential for advancements in agricultural and pharmaceutical applications. His work, characterized by innovation and collaboration, continues to contribute positively to the landscape of biotechnology. As he progresses in his career, further innovations from Schaaper are eagerly anticipated.